FACULTY
Diego J. Maselli, MD
Associate Professor of Medicine
Interim Chief, Division of Pulmonary Diseases & Critical Care
UT Health at San Antonio
Director, Respiratory Care, University Health System
Director, Severe Asthma Program, University Health System
San Antonio, TX
Njira Lugogo, MD
Professor of Medicine
Department of Medicine
Division of Pulmonary & Critical Care
University of Michigan
Ann Arbor, MI
PROGRAM OVERVIEW
This enduring activity will enhance clinicians’ ability to identify evidence-based strategies to inform prompt diagnosis, treatment selection and adjustments and reduce the occurrence of exacerbations; improve the implementation of individualized treatment plans that include patient communication, education, and shared decision-making; and design treatment regimens that incorporate guideline recommendations and emerging clinical trial data.
TARGET AUDIENCE
This CME initiative is designed to meet the educational needs of pulmonologists, respiratory technicians, and other health care providers involved in the care of adult and pediatric patients with moderate-to-severe asthma.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Translate evidence-based guidelines into clinical strategies for prompt diagnosis and treatment selection to reduce the occurrence of exacerbations
- Discuss individualized treatment plans that include communication and shared decision-making strategies for patients with asthma
- Describe the clinical data for recently approved and investigational agents for the treatment of moderate to severe asthma
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Dr. Maselli reports that he has received consulting fees and speaker honoraria from Amgen, AstraZeneca, GlaxoSmithKline, and Sanofi Regeneron.
Dr. Lugogo received consulting fees from Amgen, AstraZeneca, Avillion, Genentech, GSK, Regeneron, Sanofi, and Teva; honoraria for non-speakers bureau presentations from GSK and Astra Zeneca; and travel support from Astra Zeneca; her institution received research support from Amgen, AstraZeneca, Avillion, Evidera, Genentech, GSK, Regeneron, Sanofi, and Teva. She is an honorary faculty member of Observational and Pragmatic Research Institute (OPRI) but does not receive compensation for this role.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Tara Mayfield, MS, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
- Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
- Naomi De Brito, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures
- Participate in the enduring activity.
- Submit the evaluation form to the Med Learning Group
You will receive your certification as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For questions, please contact Med Learning Group at [email protected].
Contact this provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
RELEASED DATE: June 12, 2023
EXPIRATION DATE: June 12, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.